Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL872745

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Concentration required for the inhibition of HIV- 1 Tat-derived peptide binding to TAR RNA.
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Confidence 3 — Cell-line / Tissue
Curated By Autocuration

Target

Nucleic Acid (CHEMBL345)
Type NUCLEIC-ACID

Publication

Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics
Mei H, Galan AA, Halim NS, Mack DP, Moreland DW, Sanders KB, Hoa N. Truong, Czarnik AW
Bioorg Med Chem Lett (1995) 5 : 2755 -2760
· DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 3 5.14 6.04

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL184618 FRAMYCETIN 3.0 1 6.04
CHEMBL372795 STREPTOMYCIN 4.0 1 5.02
CHEMBL6067485 GENTAMICIN 4.0 1 4.35

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL184618 FRAMYCETIN IC50 = 920.0 nM 6.04
CHEMBL372795 STREPTOMYCIN IC50 = 9500.0 nM 5.02
CHEMBL6067485 GENTAMICIN IC50 = 45000.0 nM 4.35